237 related articles for article (PubMed ID: 29361217)
1. Progress in the Development of Preventative Drugs for Cisplatin-Induced Hearing Loss.
Hazlitt RA; Min J; Zuo J
J Med Chem; 2018 Jul; 61(13):5512-5524. PubMed ID: 29361217
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin ototoxicity and protection: clinical and experimental studies.
Rybak LP; Mukherjea D; Jajoo S; Ramkumar V
Tohoku J Exp Med; 2009 Nov; 219(3):177-86. PubMed ID: 19851045
[TBL] [Abstract][Full Text] [Related]
3. Development of Second-Generation CDK2 Inhibitors for the Prevention of Cisplatin-Induced Hearing Loss.
Hazlitt RA; Teitz T; Bonga JD; Fang J; Diao S; Iconaru L; Yang L; Goktug AN; Currier DG; Chen T; Rankovic Z; Min J; Zuo J
J Med Chem; 2018 Sep; 61(17):7700-7709. PubMed ID: 30091915
[TBL] [Abstract][Full Text] [Related]
4. Prevention and restoration of hearing loss associated with the use of cisplatin.
Chirtes F; Albu S
Biomed Res Int; 2014; 2014():925485. PubMed ID: 25140325
[TBL] [Abstract][Full Text] [Related]
5. Identification of small molecule inhibitors of cisplatin-induced hair cell death: results of a 10,000 compound screen in the zebrafish lateral line.
Thomas AJ; Wu P; Raible DW; Rubel EW; Simon JA; Ou HC
Otol Neurotol; 2015 Mar; 36(3):519-25. PubMed ID: 25687728
[TBL] [Abstract][Full Text] [Related]
6. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2012 May; (5):CD009219. PubMed ID: 22592737
[TBL] [Abstract][Full Text] [Related]
7. Hear and Now: Ongoing Clinical Trials to Prevent Drug-Induced Hearing Loss.
Lee J; Fernandez K; Cunningham LL
Annu Rev Pharmacol Toxicol; 2024 Jan; 64():211-230. PubMed ID: 37562496
[TBL] [Abstract][Full Text] [Related]
8. The role of antioxidants in protection from ototoxic drugs.
Sergi B; Fetoni AR; Ferraresi A; Troiani D; Azzena GB; Paludetti G; Maurizi M
Acta Otolaryngol Suppl; 2004 May; (552):42-5. PubMed ID: 15219046
[TBL] [Abstract][Full Text] [Related]
9. Ototoxicity: therapeutic opportunities.
Rybak LP; Whitworth CA
Drug Discov Today; 2005 Oct; 10(19):1313-21. PubMed ID: 16214676
[TBL] [Abstract][Full Text] [Related]
10. Ototoxicity.
Rybak LP; Ramkumar V
Kidney Int; 2007 Oct; 72(8):931-5. PubMed ID: 17653135
[TBL] [Abstract][Full Text] [Related]
11. Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity.
Sheehan K; Sheth S; Mukherjea D; Rybak LP; Ramkumar V
J Vis Exp; 2018 Mar; (133):. PubMed ID: 29608150
[TBL] [Abstract][Full Text] [Related]
12. Prevention of noise- and drug-induced hearing loss with D-methionine.
Campbell KC; Meech RP; Klemens JJ; Gerberi MT; Dyrstad SS; Larsen DL; Mitchell DL; El-Azizi M; Verhulst SJ; Hughes LF
Hear Res; 2007 Apr; 226(1-2):92-103. PubMed ID: 17224251
[TBL] [Abstract][Full Text] [Related]
13. Drug screening identifies aldose reductase as a novel target for treating cisplatin-induced hearing loss.
Liao Y; Mao H; Gao X; Lin H; Li W; Chen Y; Li H
Free Radic Biol Med; 2024 Jan; 210():430-447. PubMed ID: 38056576
[TBL] [Abstract][Full Text] [Related]
14. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2014 Jun; (6):CD010885. PubMed ID: 24968257
[TBL] [Abstract][Full Text] [Related]
15. Evaluating protective and therapeutic effects of alpha-lipoic acid on cisplatin-induced ototoxicity.
Kim KH; Lee B; Kim YR; Kim MA; Ryu N; Jung DJ; Kim UK; Baek JI; Lee KY
Cell Death Dis; 2018 Aug; 9(8):827. PubMed ID: 30068942
[TBL] [Abstract][Full Text] [Related]
16. Protection of Hair Cells from Ototoxic Drug-Induced Hearing Loss.
Guo J; Chai R; Li H; Sun S
Adv Exp Med Biol; 2019; 1130():17-36. PubMed ID: 30915699
[TBL] [Abstract][Full Text] [Related]
17. Prevention of hearing loss in children receiving cisplatin chemotherapy.
Freyer DR; Sung L; Reaman GH
J Clin Oncol; 2009 Jan; 27(2):317-8; author reply 318-9. PubMed ID: 19064953
[No Abstract] [Full Text] [Related]
18. Future opportunities in preventing cisplatin induced ototoxicity.
van den Berg JH; Beijnen JH; Balm AJ; Schellens JH
Cancer Treat Rev; 2006 Aug; 32(5):390-7. PubMed ID: 16781082
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, and Biological Evaluation of Dexamethasone-Salvianolic Acid B Conjugates and Nanodrug Delivery against Cisplatin-Induced Hearing Loss.
Ye R; Sun L; Peng J; Wu A; Chen X; Wen L; Bai C; Chen G
J Med Chem; 2021 Mar; 64(6):3115-3130. PubMed ID: 33666428
[TBL] [Abstract][Full Text] [Related]
20. [Detection of ototoxic effect of cisplatin with otoacoustic emission in testicular cancer patients].
Biró K
Magy Onkol; 2009 Sep; 53(3):279-83. PubMed ID: 19793694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
